ELEVAR CARE CONNECT Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for ELEVAR CARE CONNECT with the United States Patent and Trademark Office. The USPTO has given the ELEVAR CARE CONNECT trademark a serial number of 98384000. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, October 2, 2024. This trademark is owned by Elevar Therapeutics, Inc.. The ELEVAR CARE CONNECT trademark is filed in the Insurance & Financial Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Providing financial assistance for prescription costs; Providing financial information about healthcare insurance plans; Providing counseling and consulting in the field of healthcare insurance benefits; Providing healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claim processing support, and claims appeal support

Providing a website featuring information in the field of patient advocacy; Providing patient advocate services in the field of cancer treatment; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support, help with medical forms; Consulting services, namely, conducting insurance benefits investigations for pharmaceutical and biotechnology patients

Providing a website featuring medical information; Providing a website featuring information in the fields of health, cancer treatment, cancer recovery and survival, patient assistance programs that provide pharmaceuticals to help patients to get treatment, and patient advocacy and support; Providing healthcare information to patients in the field of administering medications; Providing health information in the field of cancer treatment; Charitable services, namely, patient assistance programs to provide drugs free of charge to patients without prescription drug coverage, delayed prescription coverage approval, and interruption in prescription coverage; Individual medical counseling services provided to patients; Interactive medical monitoring and alert services for reminding patients of medicinal dosage and prescription refills for medical treatment purposes
elevar care connect

General Information


Serial Number98384000
Word MarkELEVAR CARE CONNECT
Filing DateWednesday, January 31, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, October 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding financial assistance for prescription costs; Providing financial information about healthcare insurance plans; Providing counseling and consulting in the field of healthcare insurance benefits; Providing healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claim processing support, and claims appeal support
Goods and ServicesProviding a website featuring information in the field of patient advocacy; Providing patient advocate services in the field of cancer treatment; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support, help with medical forms; Consulting services, namely, conducting insurance benefits investigations for pharmaceutical and biotechnology patients
Goods and ServicesProviding a website featuring medical information; Providing a website featuring information in the fields of health, cancer treatment, cancer recovery and survival, patient assistance programs that provide pharmaceuticals to help patients to get treatment, and patient advocacy and support; Providing healthcare information to patients in the field of administering medications; Providing health information in the field of cancer treatment; Charitable services, namely, patient assistance programs to provide drugs free of charge to patients without prescription drug coverage, delayed prescription coverage approval, and interruption in prescription coverage; Individual medical counseling services provided to patients; Interactive medical monitoring and alert services for reminding patients of medicinal dosage and prescription refills for medical treatment purposes
NOT AVAILABLECARE CONNECT

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024NEW APPLICATION ENTERED
Wednesday, August 14, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 14, 2024ASSIGNED TO EXAMINER
Monday, September 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024FINAL REFUSAL WRITTEN
Wednesday, October 2, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 2, 2024FINAL REFUSAL E-MAILED